NCT04138524 (SAFIR©) is a NA clinical trial of SAFIR© in Acquired Brain Injury, sponsored by Centre Hospitalier Universitaire Vaudois.

Who is sponsoring NCT04138524?

NCT04138524 is sponsored by Centre Hospitalier Universitaire Vaudois.

What drugs are being tested in NCT04138524?

Interventions in NCT04138524: SAFIR©.

What condition does NCT04138524 study?

NCT04138524 studies Acquired Brain Injury.

Is NCT04138524 still recruiting?

NCT04138524 is currently terminated. Last updated 20 July 2022.

Last reviewed 2022-07-20 · How we verify

NCT04138524: SAFIR©

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SAFIR© : An Early Intervention for Supporting Families of Patients With Acquired Brain Injuries

Terminated NA Last updated 20 July 2022

What this trial tests

NA trial testing SAFIR© in Acquired Brain Injury in 12 participants. Terminated before completion.

Timeline

21 November 2019

Primary endpoint
30 June 2021

30 June 2021

Quick facts

Lead sponsor	Centre Hospitalier Universitaire Vaudois
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	12
Start date	21 November 2019
Primary completion	30 June 2021
Estimated completion	30 June 2021
Sites	1 location across Switzerland

Drugs / interventions tested

SAFIR©

Conditions studied

Acquired Brain Injury — all drugs for Acquired Brain Injury →

Sponsor

Centre Hospitalier Universitaire Vaudois

Who can join

18 and older, any sex, with Acquired Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate the feasibility of a newly developed intervention to improve family support for patient with acquired brain injury (ABI) in early phase of hospitalization (SAFIR): the main components are the assessment of the family, the emotional support for the families, the information giving to the families, the inclusion of the families in the care process and the care coordination between the inter professional team. The main outcomes of the study are feasibility and acceptability outcomes of the newly developed intervention, and trend in efficacy in the family functioning, coping and perceived support from the nurses.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Caring for Families of Patients With Acquired Brain Injury Early During Hospitalization: A Feasibility Study of the SAFIR<sup>©</sup> Intervention.
de Goumoëns V, Bruyere K, Rutz D, Pasquier J, et al · · 2024 · PMID 39268852 · DOI 10.1177/10748407241270034

Verify or expand the search:

Other recruiting trials for Acquired Brain Injury

Currently open trials in the same condition.

NCT07378592 — Driving Simulator Training For Adults With Acquired Brain Injuries · NA · recruiting
NCT07435155 — ACURES: Acoustic and Respiratory Parameters for Dysarthria Assessment · recruiting
NCT07237386 — Comparing the Ceriter Stride One, a Pressure-sensitive Smart Insole, With Gait Parameters Measured on the GRAIL in Neuro · NA · recruiting
NCT06848140 — Using Non-invasive Brain Stimulation to Treat Word Finding Difficulty in Chronic Traumatic Brain Injury · NA · recruiting
NCT07122752 — Feasibility and Outcomes of 3D-printed External Cranial Orthosis After Craniectomy · active not recruiting

Other Centre Hospitalier Universitaire Vaudois trials

Trials by the same sponsor.

NCT07427511 — SwissNeuroRehab - HDHI · NA · recruiting
NCT07263438 — Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a · Phase 2 · recruiting
NCT07139756 — Deciphering the Mechanisms of Central BP Regulation in Patients With PD Associated With Orthostatic Hypotension · not yet recruiting
NCT07109388 — Comparison of Pericapsular Nerve Group (PENG) Block With a Combined Femoral, Sciatic, Lateral Femoral Cutaneous Nerve Bl · NA · not yet recruiting
NCT07268378 — Supervision of Clinicians in Oncology by Psycho-oncologists : Evaluation · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04138524 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire Vaudois
Last refreshed: 20 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04138524.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing